|

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2025-08-13
Est. completion2029-06-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06910969

Summary

The goal of this study is to demonstrate the efficacy of a multidisciplinary group-based telehealth intervention (HORIZONS) compared to minimally enhanced usual care for improving self-management and quality of life for hematopoietic stem cell transplant (HSCT) survivors living with chronic graft-versus host disease, and to identify critical facilitators and barriers for HORIZONS implementation and adoption.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients (≥ 18 years) who have undergone allogeneic HCT
* Have moderate to severe cGVHD based on patient-report
* Have ability to participate in English or Spanish language group telehealth intervention.

Exclusion Criteria:

* Patients with mild cGVHD based on their self-report.
* Patients with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent.

Conditions3

Bone Marrow Transplant ComplicationsCancerGraft-versus-host-disease

Locations2 sites

Florida

1 site
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, 33136
Lara Traeger, PhD(305) 243-5302ltraeger@miami.edu

Massachusetts

1 site
Massachusetts General Hospital
Boston, Massachusetts, 02114
Areej El-Jawahri617-724-4000ael-jawahri@mgb.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.